PTGES and cancer: To specifically reduce PGE2 levels while sparing these other essential metabolites, we [6, 7] and others [8] have targeted the inducible terminal enzyme, microsomal PGE synthase-1 (mPGES-1; Ptges), as an alternative therapy for managing inflammation and cancer.